Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical company reports results for the 2004 fourth quarter and full year
March 3rd, 2005
Wyeth (WYE) reported results for the 2004 fourth quarter and full year. Worldwide net revenue increased 7% to $4.6 billion for the 2004 fourth quarter and 10% to $17.4 billion for the 2004 full year. Excluding the favorable impact of foreign exchange, worldwide net revenue increased 5% and 7% for the 2004 fourth quarter and full year, respectively. Currently the number one selling antidepressant globally, Effexor and Effexor XR, achieved worldwide net revenue of $3.3 billion for the year, an increase of 23%, exceeding its longstanding goal of $3 billion in annual net revenue in 2004 and becoming Wyeth's first $3 billion product. This solid...
Source: Women's Health Weekly (2005-03-03)
|
